Market Overview:
The global soluble epoxide hydrolase market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for novel therapeutics. In addition, technological advancements in the field of soluble epoxide hydrolase are also contributing to the growth of this market. On the basis of type, GSK-2256294 is expected to account for a major share of the global soluble epoxide hydrolase market during the forecast period. This can be attributed to its high efficacy and safety profile. On the basis of application, hospital is expected to account for a major share of this market duringthe forecast period owingtoits large patient base and growing demand for novel therapeutics.
Product Definition:
The soluble epoxide hydrolase (sEH) is a key enzyme in the metabolism of epoxyeicosatrienoic acids (EETs), which are important lipid mediators with diverse biological activities.
GSK-2256294:
GSK-2256294 is an investigational drug developed by GSK for the treatment of Epoetin Alfa (EPA) deficiency. It has been tested on patients with a rare genetic disorder, porfimer sodium sensitivity, which causes severe health problems including organ failure.
EC-5026:
EC-5026 is a novel oral inhibitor of soluble epoxide hydrolase (sEH) with moderate affinity for the sEH substrate. EC-5026 has completed phase 2 clinical trials and is expected to be launched in 2019. It has been found to have an improved safety/toxicology profile when compared to other sEH inhibitors currently in development, including those having higher target selectivity such as ABT-126 and LYNPARZA.
Application Insights:
The others segment held the largest market share of more than 40% in 2017. The application includes food processing, paper manufacturing and water treatment among others. Soluble epoxide hydrolase has been reported to be present in various plants, animals and microbes which include fungi, bacteria and eukaryotic cells such as yeast. It is extensively used for industrial purposes owing to its specificity towards epoxides which are widely utilized across several industries including pharmaceuticals, coatings & adhesives and printing ink among others.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region over the forecast period. The growth can be attributed to rising disposable income, increasing awareness about early diagnosis of cancer and other diseases, and availability of effective treatment in this region. In addition, government initiatives for improving healthcare infrastructure are likely to boost market growth in Asia Pacific during the forecast period.
Europe accounted for a significant share of revenue in 2017 owing to high prevalence of cancer and other chronic diseases such as diabetes, arthritis, & cardiovascular disease (CVD). According to statistics published by European Cancer Observatory (ECO), around 595 thousand new cases were reported in Europe during 2016 – 2017; out of which 498 cases were diagnosed among men while 543 cases were diagnosed among women. Such high prevalence levels are anticipated to boost product demand over the forecast period.
In addition, presence or development programs by pharmaceutical companies such as Novartis AG & Co., Ltd.; Pfizer Inc.
Growth Factors:
- Increasing demand for soluble epoxide hydrolase inhibitors in the pharmaceutical industry for the treatment of various diseases is expected to drive the growth of soluble epoxide hydrolase market.
- Growing research and development activities for novel drug discovery is also anticipated to fuel the growth of soluble epoxide hydrolase market over the forecast period.
- Rising prevalence of cardiovascular diseases, asthma, and other respiratory disorders is expected to create a high demand for soluble epoxide hydrolase inhibitors in coming years.
- The increasing use of soluable epoxide hydrolases as biomarkers for early detection and diagnosis of various diseases is projected to boost the growth prospects of this market during forecast period 2017-2025
Scope Of The Report
Report Attributes
Report Details
Report Title
Soluble Epoxide Hydrolase Market Research Report
By Type
GSK-2256294, EC-5026, Others
By Application
Hospital, Clinic, Others
By Companies
GlaxoSmithKline Plc, Sphaera Pharma Pvt. Ltd., Sumitomo Dainippon Pharma Co., Ltd., Toray Industries, Inc., GlaxoSmithKline Plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Soluble Epoxide Hydrolase Market Report Segments:
The global Soluble Epoxide Hydrolase market is segmented on the basis of:
Types
GSK-2256294, EC-5026, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline Plc
- Sphaera Pharma Pvt. Ltd.
- Sumitomo Dainippon Pharma Co., Ltd.
- Toray Industries, Inc.
- GlaxoSmithKline Plc
Highlights of The Soluble Epoxide Hydrolase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- GSK-2256294
- EC-5026
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Soluble Epoxide Hydrolase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Soluble epoxide hydrolase is an enzyme that catalyzes the hydrolysis of soluble epoxides to their alcohols and water. This reaction is important in the degradation of many environmental pollutants, such as polycyclic aromatic hydrocarbons (PAHs).
Some of the major players in the soluble epoxide hydrolase market are GlaxoSmithKline Plc, Sphaera Pharma Pvt. Ltd., Sumitomo Dainippon Pharma Co., Ltd., Toray Industries, Inc., GlaxoSmithKline Plc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Soluble Epoxide Hydrolase Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Soluble Epoxide Hydrolase Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Soluble Epoxide Hydrolase Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Soluble Epoxide Hydrolase Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Soluble Epoxide Hydrolase Market Size & Forecast, 2020-2028
4.5.1 Soluble Epoxide Hydrolase Market Size and Y-o-Y Growth
4.5.2 Soluble Epoxide Hydrolase Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 GSK-2256294
5.2.2 EC-5026
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Soluble Epoxide Hydrolase Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Soluble Epoxide Hydrolase Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 GSK-2256294
9.6.2 EC-5026
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 GSK-2256294
10.6.2 EC-5026
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 GSK-2256294
11.6.2 EC-5026
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 GSK-2256294
12.6.2 EC-5026
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 GSK-2256294
13.6.2 EC-5026
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Soluble Epoxide Hydrolase Market: Competitive Dashboard
14.2 Global Soluble Epoxide Hydrolase Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline Plc
14.3.2 Sphaera Pharma Pvt. Ltd.
14.3.3 Sumitomo Dainippon Pharma Co., Ltd.
14.3.4 Toray Industries, Inc.
14.3.5 GlaxoSmithKline Plc
